دورية أكاديمية
Current status and practical considerations of artificial intelligence use in screening and diagnosing retinal diseases: Vision Academy retinal expert consensus.
| العنوان: | Current status and practical considerations of artificial intelligence use in screening and diagnosing retinal diseases: Vision Academy retinal expert consensus. |
|---|---|
| المؤلفون: | Chou YB; Department of Ophthalmology, Taipei Veterans General Hospital.; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan., Kale AU; Academic Unit of Ophthalmology, Institute of Inflammation & Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Lanzetta P; Department of Medicine - Ophthalmology, University of Udine.; Istituto Europeo di Microchirurgia Oculare, Udine, Italy., Aslam T; Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester School of Health Sciences, Manchester, UK., Barratt J; International Federation on Ageing, Toronto, Canada., Danese C; Department of Medicine - Ophthalmology, University of Udine.; Department of Ophthalmology, AP-HP Hôpital Lariboisière, Université Paris Cité, Paris, France., Eldem B; Department of Ophthalmology, Hacettepe University, Ankara, Turkey., Eter N; Department of Ophthalmology, University of Münster Medical Center, Münster, Germany., Gale R; Department of Ophthalmology, York Teaching Hospital NHS Foundation Trust, York, UK., Korobelnik JF; Service d'ophtalmologie, CHU Bordeaux.; University of Bordeaux, INSERM, BPH, UMR1219, F-33000 Bordeaux, France., Kozak I; Moorfields Eye Hospital Centre, Abu Dhabi, UAE., Li X; Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin., Li X; Xiamen Eye Center, Xiamen University, Xiamen, China., Loewenstein A; Division of Ophthalmology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Ruamviboonsuk P; Department of Ophthalmology, College of Medicine, Rangsit University, Rajavithi Hospital, Bangkok, Thailand., Sakamoto T; Department of Ophthalmology, Kagoshima University, Kagoshima, Japan., Ting DSW; Singapore National Eye Center, Duke-NUS Medical School, Singapore., van Wijngaarden P; Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, Australia.; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia., Waldstein SM; Department of Ophthalmology, Landesklinikum Mistelbach-Gänserndorf, Mistelbach, Austria., Wong D; Unity Health Toronto - St. Michael's Hospital, University of Toronto, Toronto, Canada., Wu L; Macula, Vitreous and Retina Associates of Costa Rica, San José, Costa Rica., Zapata MA; Ophthalmology Department, Hospital Vall d'Hebron., Zarranz-Ventura J; Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain. |
| المصدر: | Current opinion in ophthalmology [Curr Opin Ophthalmol] 2023 Sep 01; Vol. 34 (5), pp. 403-413. Date of Electronic Publication: 2023 Jul 13. |
| نوع المنشور: | Review; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9011108 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-7021 (Electronic) Linking ISSN: 10408738 NLM ISO Abbreviation: Curr Opin Ophthalmol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Hagerstown, MD : Lippincott Williams & Wilkins Original Publication: Philadelphia, PA : Current Science, c1990- |
| مواضيع طبية MeSH: | Artificial Intelligence* , Retinal Diseases*/diagnosis, Humans ; Consensus ; Ecosystem ; Algorithms |
| مستخلص: | Purpose of Review: The application of artificial intelligence (AI) technologies in screening and diagnosing retinal diseases may play an important role in telemedicine and has potential to shape modern healthcare ecosystems, including within ophthalmology. Recent Findings: In this article, we examine the latest publications relevant to AI in retinal disease and discuss the currently available algorithms. We summarize four key requirements underlining the successful application of AI algorithms in real-world practice: processing massive data; practicability of an AI model in ophthalmology; policy compliance and the regulatory environment; and balancing profit and cost when developing and maintaining AI models. Summary: The Vision Academy recognizes the advantages and disadvantages of AI-based technologies and gives insightful recommendations for future directions. (Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.) |
| References: | McCarthy J, Minsky ML, Rochester N, Shannon CE. A proposal for the Dartmouth summer research project on artificial intelligence, August 31, 1955. AI Mag 2006; 27:1214. Samuel AL. Some studies in machine learning using the game of checkers. IBM J 1959; 3:535554. Bengio Y, Courville A, Vincent P. Representation learning: a review and new perspectives. IEEE Trans Pattern Anal Mach Intell 2013; 35:17981828. LeCun Y, Bengio Y, Hinton G. Deep learning. Nature 2015; 521:436444. Krizhevsky A, Sutskever I, Hinton GE. ImageNet classification with deep convolutional neural networks. Commun ACM 2017; 60:8490. Abràmoff MD, Lou Y, Erginay A, et al. Improved automated detection of diabetic retinopathy on a publicly available dataset through integration of deep learning. Invest Ophthalmol Vis Sci 2016; 57:52005206. Gulshan V, Peng L, Coram M, et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA 2016; 316:24022410. Ting DSW, Cheung CY-L, Lim G, et al. Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes. JAMA 2017; 318:22112223. Gargeya R, Leng T. Automated identification of diabetic retinopathy using deep learning. Ophthalmology 2017; 124:962969. Burlina PM, Joshi N, Pekala M, et al. Automated grading of age-related macular degeneration from color fundus images using deep convolutional neural networks. JAMA Ophthalmol 2017; 135:11701176. Grassmann F, Mengelkamp J, Brandl C, et al. A deep learning algorithm for prediction of age-related eye disease study severity scale for age-related macular degeneration from color fundus photography. Ophthalmology 2018; 125:14101420. Brown JM, Campbell JP, Beers A, et al. Automated diagnosis of plus disease in retinopathy of prematurity using deep convolutional neural networks. JAMA Ophthalmol 2018; 136:803810. Sun G, Wang X, Xu L, et al. Deep learning for the detection of multiple fundus diseases using ultra-widefield images. Ophthalmol Ther 2023; 12:895907. Li B, Chen H, Zhang B, et al. Development and evaluation of a deep learning model for the detection of multiple fundus diseases based on colour fundus photography. Br J Ophthalmol 2022; 106:10791086. Abitbol E, Miere A, Excoffier JB, et al. Deep learning-based classification of retinal vascular diseases using ultra-widefield colour fundus photographs. BMJ Open Ophthalmol 2022; 7:e000924. Cai S, Parker F, Urias MG, et al. Deep learning detection of sea fan neovascularization from ultra-widefield color fundus photographs of patients with sickle cell hemoglobinopathy. JAMA Ophthalmol 2021; 139:206213. Wang Z, Hu ZJ. Artificial intelligence for assessment of Stargardt macular atrophy. Neural Regen Res 2022; 17:26322636. Miere A, Le Meur T, Bitton K, et al. Deep learning-based classification of inherited retinal diseases using fundus autofluorescence. J Clin Med 2020; 9:3303. Fujinami-Yokokawa Y, Ninomiya H, Liu X, et al. Prediction of causative genes in inherited retinal disorder from fundus photography and autofluorescence imaging using deep learning techniques. Br J Ophthalmol 2021; 105:12721279. Lee CS, Baughman DM, Lee AY. Deep learning is effective for the classification of OCT images of normal versus age-related macular degeneration. Ophthalmol Retina 2017; 1:322327. Schmidt-Erfurth U, Vogl WD, Jampol LM, Bogunović H. Application of automated quantification of fluid volumes to anti-VEGF therapy of neovascular age-related macular degeneration. Ophthalmology 2020; 127:12111219. Schlegl T, Waldstein SM, Bogunovic H, et al. Fully automated detection and quantification of macular fluid in OCT using deep learning. Ophthalmology 2018; 125:549558. De Fauw J, Ledsam JR, Romera-Paredes B, et al. Clinically applicable deep learning for diagnosis and referral in retinal disease. Nat Med 2018; 24:13421350. Oh E, Yoo TK, Park EC. Diabetic retinopathy risk prediction for fundus examination using sparse learning: a cross-sectional study. BMC Med Inform Decis Mak 2013; 13:106. Mordi IR, Trucco E, Syed MG, et al. Prediction of major adverse cardiovascular events from retinal, clinical, and genomic data in individuals with type 2 diabetes: a population cohort study. Diabetes Care 2022; 45:710716. Veturi YA, Woof W, Lazebnik T, et al. SynthEye: investigating the impact of synthetic data on artificial intelligence-assisted gene diagnosis of inherited retinal disease. Ophthalmol Sci 2023; 3:100258. Lakhani P, Sundaram B. Deep learning at chest radiography: automated classification of pulmonary tuberculosis by using convolutional neural networks. Radiology 2017; 284:574582. Executive Office of the President, National Science and Technology Council Committee on Technology. Preparing for the future of artificial intelligence. 2016. Available at: https://obamawhitehouse.archives.gov/sites/default/files/whitehouse_files/microsites/ostp/NSTC/preparing_for_the_future_of_ai.pdf?source=post_elevate_sequence_page . [Accessed January 2023]. Lee AY, Campbell JP, Hwang TS, et al. Recommendations for standardization of images in ophthalmology. Ophthalmology 2021; 128:969970. Chiang MF, Boland MV, Brewer A, et al. Special requirements for electronic health record systems in ophthalmology. Ophthalmology 2011; 118:16811687. Khan SM, Liu X, Nath S, et al. A global review of publicly available datasets for ophthalmological imaging: barriers to access, usability, and generalisability. Lancet Digit Health 2021; 3:e51e66. Narayanan A, Shmatikov V. Robust de-anonymization of large sparse datasets. 2008; Oakland, CA, USA: IEEE Symposium on Security and Privacy, 111–125. Akram MU, Abdul Salam A, Khawaja SG, et al. RIDB: a dataset of fundus images for retina based person identification. Data Brief 2020; 33:106433. Imtiaz S, Arsalan M, Vlassov V, Sadre R. Synthetic and private smart health care data generation using GANs. IoTSPT-ML Workshop, International Conference on Computer Communications and Networks (ICCCN), Athens, Greece, 2021:1–7. Kaur D, Sobiesk M, Patil S, et al. Application of Bayesian networks to generate synthetic health data. J Am Med Inform Assoc 2021; 28:801811. Yang Q, Liu Y, Chen T, Tong Y. Federated machine learning: concept and applications. ACM Trans Intell Syst Technol 2019; 10:Article 12. Warnat-Herresthal S, Schultze H, Shastry KL, et al. Swarm learning for decentralized and confidential clinical machine learning. Nature 2021; 594:265270. Lo J, Yu TT, Ma D, et al. Federated learning for microvasculature segmentation and diabetic retinopathy classification of OCT data. Ophthalmol Sci 2021; 1:100069. Evans NG, Wenner DM, Cohen IG, et al. Emerging ethical considerations for the use of artificial intelligence. Ophthalmol Sci 2022; 2:100141. American Medical Association. Augmented intelligence in health care. 2019. Available at: https://www.ama-assn.org/system/files/2019-08/ai-2018-board-policy-summary.pdf [Accessed January 2023]. Vladeck DC. Machines without principals: liability rules and artificial intelligence. Wash L Rev 2014; 89:117150. He J, Baxter SL, Xu J, et al. The practical implementation of artificial intelligence technologies in medicine. Nat Med 2019; 25:3036. Abdullah YI, Schuman JS, Shabsigh R, et al. Ethics of artificial intelligence in medicine and ophthalmology. Asia Pac J Ophthalmol (Phila) 2021; 10:289298. Liu X, Cruz Rivera S, Moher D, et al. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Lancet Digit Health 2020; 2:e537e548. Vasey B, Nagendran M, Campbell B, et al. Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI. Nat Med 2022; 28:924933. Collins GS, Dhiman P, Andaur Navarro CL, et al. Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence. BMJ Open 2021; 11:e048008. Ibrahim H, Liu X, Zariffa N, et al. Health data poverty: an assailable barrier to equitable digital health care. Lancet Digit Health 2021; 3:e260e265. European Parliament, Council of the European Union. Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation). 2016. Available at: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32016R0679&qid=1681141616075 [Accessed March 2023]. European Parliament, Council of the European Union. Directive (EU) 2016/1148 of the European Parliament and of the Council of 6 July 2016 concerning measures for a high common level of security of network and information systems across the Union. 2016. Available at: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32016L1148&qid=1681141655153 [Accessed March 2023]. European Parliament, Council of the European Union. Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC. 2017. Available at: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32017R0745&qid=1681141585854 [Accessed March 2023]. Goodman B, Flaxman S. European Union regulations on algorithmic decision-making and a “right to explanation”. AI Mag 2017; 38:5057. International Medical Device Regulators Forum. Software as a Medical Device (SaMD): key definitions. 2013. Available at: https://www.imdrf.org/sites/default/files/docs/imdrf/final/technical/imdrf-tech-131209-samd-key-definitions-140901.pdf [Accessed January 2023]. Ting DSW, Lee AY, Wong TY. An ophthalmologist's guide to deciphering studies in artificial intelligence. Ophthalmology 2019; 126:14751479. European Commission. Proposal for a regulation of the European Parliament and of the council laying down harmonised rules on artificial intelligence (Artificial Intelligence Act) and amending certain union legislative acts, COM(2021) 206. 2021. Available at: https://eur-lex.europa.eu/resource.html?uri=cellar:e0649735-a372-11eb-9585-01aa75ed71a1.0001.02/DOC_1&format=PDF [Accessed January 2023]. Ruamviboonsuk P, Chantra S, Seresirikachorn K, et al. Economic evaluations of artificial intelligence in ophthalmology. Asia Pac J Ophthalmol 2021; 10:307316. Chen EM, Chen D, Chilakamarri P, et al. Economic challenges of artificial intelligence adoption for diabetic retinopathy. Ophthalmology 2021; 128:475477. Nguyen HV, Tan GSW, Tapp RJ, et al. Cost-effectiveness of a national telemedicine diabetic retinopathy screening program in Singapore. Ophthalmology 2016; 123:25712580. Greaves F, Joshi I, Campbell M, et al. What is an appropriate level of evidence for a digital health intervention? Lancet 2019; 392:26652667. Intelligent Retinal Imaging Systems. iris™. 2023. Available at: https://retinalscreenings.com/ [Accessed March 2023]. Google Health. Automated Retinal Disease Assessment. 2023. Available at: https://health.google/caregivers/arda/ [Accessed March 2023]. EyRIS Pte Ltd. Technology behind SELENA+. 2023. Available at: https://www.eyris.io/technology.cfm [Accessed March 2023]. Digital Diagnostics. IDx-DR. 2023. Available at: https://www.digitaldiagnostics.com/products/eye-disease/idx-dr-eu/ [Accessed March 2023]. Remidio Innovative Solutions. Medios DR. 2023. Available at: https://www.remidio.com/products/medios-dr . [Accessed March 2023]. Thirona Retina. RetCAD™. Available at: https://retcad.thirona.eu/ [Accessed March 2023]. Eyenuk. EyeArt ® AI Eye Screening System. Available at: https://www.eyenuk.com/en/products/eyeart/ [Accessed March 2023]. VUNO. VUNO Med-Fundus AI. 2023. Available at: https://www.vuno.co/en/fundus [Accessed March 2023]. Toku Eyes. Introducing THEIA™. 2023. Available at: https://tokueyes.com/theia/ [Accessed March 2023]. iHealthScreen. iPredict. 2020. Available at: https://ihealthscreen.org/ [Accessed March 2023]. Notal Vision. Notal Home OCT. 2023. Available at: https://notalvision.com/technology/home-oct [Accessed March 2023]. OphtAI. Artificial intelligence dedicated to ophthalmology | Home. 2023. Available at: https://www.ophtai.com/en/ [Accessed March 2023]. Retmarker, a METEDA company. Retmarker. 2023. Available at: https://www.retmarker.com/ [Accessed March 2023]. RetinaLyze System A/S. RetinaLyze ® . 2020. Available at: https://www.retinalyze.com/ [Accessed March 2023]. RetinAI. RetinAI Discovery ® . 2022. Available at: https://www.retinai.com/products/discovery [Accessed March 2023]. European Commission. EUDAMED database. 2023. Available at: https://ec.europa.eu/tools/eudamed/#/screen/home [Accessed January 2023]. US Food and Drug Administration. Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices. 2022. Available at: https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices [Accessed January 2023]. US Food and Drug Administration. 510(k) Premarket Notification. 2023. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm [Accessed January 2023]. Walton OB IV, Garoon RB, Weng CY, et al. Evaluation of automated teleretinal screening program for diabetic retinopathy. JAMA Ophthalmol 2016; 134:204209. Gulshan V, Rajan RP, Widner K, et al. Performance of a deep-learning algorithm vs manual grading for detecting diabetic retinopathy in India. JAMA Ophthalmol 2019; 137:987993. van der Heijden AA, Abramoff MD, Verbraak F, et al. Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System. Acta Ophthalmol 2018; 96:6368. Wong DCS, Kiew G, Jeon S, Ting D. Singapore Eye Lesions Analyzer (SELENA): The Deep Learning System for Retinal Diseases. In: Grzybowski, A., editor. Artificial Intelligence in Ophthalmology. New York, NY, USA: Springer; 2021. pp. 177–185. Abràmoff MD, Lavin PT, Birch M, et al. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digit Med 2018; 1:39. Natarajan S, Jain A, Krishnan R, et al. Diagnostic accuracy of community-based diabetic retinopathy screening with an offline artificial intelligence system on a smartphone. JAMA Ophthalmol 2019; 137:11821188. González-Gonzalo C, Sánchez-Gutiérrez V, Hernández-Martínez P, et al. Evaluation of a deep learning system for the joint automated detection of diabetic retinopathy and age-related macular degeneration. Acta Ophthalmol 2020; 98:368377. Ipp E, Liljenquist D, Bode B, et al. Pivotal evaluation of an artificial intelligence system for autonomous detection of referrable and vision-threatening diabetic retinopathy. JAMA Netw Open 2021; 4:e2134254. Son J, Shin JY, Kim HD, et al. Development and validation of deep learning models for screening multiple abnormal findings in retinal fundus images. Ophthalmology 2020; 127:8594. Vaghefi E, Hill S, Kersten HM, Squirrell D. Multimodal retinal image analysis via deep learning for the diagnosis of intermediate dry age-related macular degeneration: a feasibility study. J Ophthalmol 2020; 2020:7493419. Xie L, Yang S, Squirrell D, Vaghefi E. Towards implementation of AI in New Zealand national screening program: cloud-based, robust, and bespoke. PLoS One 2020; 15:e0225015. Vaghefi E, Yang S, Xie L, et al. THEIA™ development, and testing of artificial intelligence-based primary triage of diabetic retinopathy screening images in New Zealand. Diabet Med 2021; 38:e14386. Bhuiyan A, Govindaiah A, Alauddin S, et al. Combined automated screening for age-related macular degeneration and diabetic retinopathy in primary care settings. Ann Eye Sci 2021; 6:12. Kim JE, Tomkins-Netzer O, Elman MJ, et al. Evaluation of a self-imaging SD-OCT system designed for remote home monitoring. BMC Ophthalmol 2022; 22:261. Liu Y, Holekamp NM, Heier JS. Prospective, longitudinal study: daily self-imaging with home OCT for neovascular age-related macular degeneration. Ophthalmol Retina 2022; 6:575585. Lee AY, Yanagihara RT, Lee CS, et al. Multicenter, head-to-head, real-world validation study of seven automated artificial intelligence diabetic retinopathy screening systems. Diabetes Care 2021; 44:11681175. Tufail A, Kapetanakis VV, Salas-Vega S, et al. An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectiveness. Health Technol Assess 2016; 20:172. Hansen AB, Hartvig NV, Jensen MS, et al. Diabetic retinopathy screening using digital non-mydriatic fundus photography and automated image analysis. Acta Ophthalmol Scand 2004; 82:666672. Larsen M, Godt J, Larsen N, et al. Automated detection of fundus photographic red lesions in diabetic retinopathy. Invest Ophthalmol Vis Sci 2003; 44:761766. Rodríguez-Esteve P, Gonzalez-Hernandez M, Pareja-Rios A, Gonzalez de la Rosa M. Non invasive evaluation of the aging of the cristaline lens in normals and diabetics. Invest Ophthalmol Vis Sci; ARVO Annual Meeting, May 1–7, 2021. Abstract 72. Rocha JAG, Dias DT, Lemos MBC, et al. Optic nerve head hemoglobin levels in glaucoma: a structural and functional correlation study. J Ophthalmol 2021; 2021:9916102. Montesel A, Gigon A, Mosinska A, et al. Automated foveal location detection on spectral-domain optical coherence tomography in geographic atrophy patients. Graefes Arch Clin Exp Ophthalmol 2022; 260:22612270. Derradji Y, Mosinska A, Apostolopoulos S, et al. Fully-automated atrophy segmentation in dry age-related macular degeneration in optical coherence tomography. Sci Rep 2021; 11:21893. Mantel I, Mosinska A, Bergin C, et al. Automated quantification of pathological fluids in neovascular age-related macular degeneration, and its repeatability using deep learning. Transl Vis Sci Technol 2021; 10:17. Martin-Pinardel R, Izquierdo-Serra J, De Zanet S, et al. Artificial intelligence-based fluid quantification and associated visual outcomes in a real-world, multicentre neovascular age-related macular degeneration national database. Br J Ophthalmol 2023; doi: 10.1136/bjo-2022-322297. (PMID: 10.1136/bjo-2022-322297) Habra O, Gallardo M, Meyer zu Westram T, et al. Evaluation of an artificial intelligence-based detector of sub- and intraretinal fluid on a large set of optical coherence tomography volumes in age-related macular degeneration and diabetic macular edema. Ophthalmologica 2022; 245:516527. |
| تواريخ الأحداث: | Date Created: 20230616 Date Completed: 20230814 Latest Revision: 20230814 |
| رمز التحديث: | 20230814 |
| مُعرف محوري في PubMed: | PMC10399944 |
| DOI: | 10.1097/ICU.0000000000000979 |
| PMID: | 37326222 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!